A pilot study of dronabinol for the treatment of pain in sickle cell disease
Abstract Background: Many adults living with sickle cell disease (SCD) suffer from chronic pain, turning to cannabis for relief. However,…
dronabinol
Therapeutic potential of cannabinoids for treating atopic dermatitis
Abstract This review aims to assess the therapeutic potential of cannabinoids as complementary treatments for atopic dermatitis. Atopic dermatitis (AD)…
Dronabinol Is Not a Game Changer in Pediatric Palliative Care: Results from a Retrospective Study
Abstract Background/Objectives: Patients with life-limiting conditions (LLCs) often suffer from restlessness, spasticity, pain, and seizures. Dronabinol (DRB) may have a…
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation
Abstract This study establishes a fetal cannabinoid syndrome model to evaluate the effects of high doses of dronabinol (synthetic THC)…
Cannabinoid-Associated Hyperemesis Syndrome Treated With Dronabinol: Killing a Poison With the Poison
Abstract Cannabinoid hyperemesis syndrome (CHS) is a medical condition characterized by recurrent nausea, vomiting, and abdominal pain in individuals who…
DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats
Abstract Introduction: Dimethyl sulfoxide (DMSO) is an amphipathic molecule with innate biological activity that also is used to dissolve both…
Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Abstract Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol…
Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial)
Abstract Background: Distressing nightmares are a core symptom of posttraumatic stress disorder (PTSD) and contribute to psychiatric comorbidity, impaired physical…
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Abstract Substance-use disorders are pervasive, comorbid with a plethora of disease and possess limited treatment options. Medicinal cannabinoids have been…
Evaluation of morphine, methadone, digoxin, and dronabinol poisoning during the years 2017 to 2019 in Ilam, Iran
Abstract Background: Every year, drug poisoning is the most prevalent reason for referring patients to medical centers. This study aimed…